NDC codes

FDA NDC Directory
Product NDC (as listed)50268-202Labeler and product segments. Claims need a package NDC.
Product NDC at billing width50268-0202Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
50268-202-15502680202155026802021550 BLISTER PACK in 1 BOX (50268-202-15) / 1 TABLET in 1 BLISTER PACK (50268-202-11)Marketed from Jun 23, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Carbidopa and Levodopa
Generic name (nonproprietary)
carbidopa and levodopa
Active ingredients
Carbidopa — 25 mg/1Levodopa — 100 mg/1
Dosage form
Tablet
Route
Oral
Labeler
AvPAKNDC labeler code 50268
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 073589
Marketing start
Listing expires
Other FDA classes
Aromatic (Chemical structure)
Identifiers
Product ID 50268-202_54f30b53-6bd0-225e-e063-6294a90af421SPL ID 54f30b53-6bd0-225e-e063-6294a90af421SPL set ID 54f30abc-97fa-00f0-e063-6394a90a155dRxCUI 197444UNII MNX7R8C5VO, 46627O600J
Pharmacologic class
Aromatic Amino Acid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450268020215 followed by a unit qualifier and the quantity

Package 50268-0202-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Carbidopa and levodopa tablets, USP are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. Carbi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50268-202

What is NDC 50268-202?
50268-202 is the product NDC for Carbidopa and Levodopa, Carbidopa 25 mg/1; Levodopa 100 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Carbidopa and Levodopa.
What is the active ingredient?
Carbidopa, Levodopa.
Who is the labeler?
AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carbidopa and Levodopa?
97 other product NDCs are listed under this name. See all Carbidopa and Levodopa NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carbidopa and Levodopa NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Carbidopa and LevodopaCarbidopa 25 mg/1; Levodopa 250 mg/1TabletOralCoupler LLC67046-168967046-1689-03
Carbidopa and LevodopaCarbidopa 48.75 mg/1; Levodopa 195 mg/1Capsule, Extended releaseOralREMEDYREPACK INC.70518-462170518-4621-00
Carbidopa and LevodopaCarbidopa 23.75 mg/1; Levodopa 95 mg/1Capsule, Extended releaseOralREMEDYREPACK INC.70518-461870518-4618-00
Carbidopa and LevodopaCarbidopa 25 mg/1; Levodopa 250 mg/1TabletOralREMEDYREPACK INC.70518-462070518-4620-00
Carbidopa and LevodopaCarbidopa 36.25 mg/1; Levodopa 145 mg/1Capsule, Extended releaseOralREMEDYREPACK INC.70518-463070518-4630-00
Carbidopa and LevodopaCarbidopa 61.25 mg/1; Levodopa 245 mg/1Capsule, Extended releaseOralREMEDYREPACK INC.70518-461070518-4610-00
Carbidopa And LevodopaCarbidopa 25 mg/1; Levodopa 250 mg/1TabletOralCoupler LLC67046-166867046-1668-03
Carbidopa and LevodopaCarbidopa hydrate 25 mg/1; Levodopa 100 mg/1Tablet, Extended releaseOralSafecor Health, LLC48433-01548433-0015-20
Carbidopa and LevodopaCarbidopa hydrate 50 mg/1; Levodopa 200 mg/1Tablet, Extended releaseOralSafecor Health, LLC48433-01648433-0016-20
Carbidopa And LevodopaCarbidopa 25 mg/1; Levodopa 100 mg/1TabletOralAphena Pharma Solutions - Tennessee, LLC53401-02053401-0020-6053401-0020-80

All 98 Carbidopa and Levodopa NDCs

Other NDCs under ANDA 073589

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073589
ProductStrengthForm · routeLabelerProduct NDC
Carbidopa and LevodopaCarbidopa 25 mg/1; Levodopa 100 mg/1TabletOralNCS HealthCare of KY, LLC dba Vangard Labs0615-8536
Carbidopa and LevodopaCarbidopa hydrate 25 mg/1; Levodopa 100 mg/1TabletOralMajor Pharmaceuticals0904-7501
Carbidopa and LevodopaCarbidopa hydrate 25 mg/1; Levodopa 100 mg/1TabletOralCardinal Health 107, LLC55154-2643
Carbidopa and LevodopaCarbidopa 25 mg/1; Levodopa 100 mg/1TabletOralDr. Reddy's Laboratories Inc75907-020

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in